 | • レポートコード：MRC2303I0224 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の獣医麻酔市場規模が、予測期間中に年平均6.5%で成長すると予測しています。本書では、獣医麻酔の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（オントロリー型、壁掛け型、卓上型）分析、動物別（コンパニオンアニマル、家畜動物）分析、地域別（北米、ヨーロッパ、アジア太平洋、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、JD Medical Dist. Co. Inc.、Kent Scientific Corporation、Midmark Corporation、Mindray Medical International Limited、Patterson Scientific、 ICU Medical, Inc.、Supera Anesthesia Innovations、Tecnologia Veterinaria y Medica, S.Lなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の獣医麻酔市場規模：製品別 - オントロリー型獣医麻酔の市場規模 - 壁掛け型獣医麻酔の市場規模 - 卓上型獣医麻酔の市場規模 ・世界の獣医麻酔市場規模：動物別 - コンパニオンアニマルにおける市場規模 - 家畜動物における市場規模 ・世界の獣医麻酔市場規模：地域別 - 北米の獣医麻酔市場規模 アメリカの獣医麻酔市場規模 カナダの獣医麻酔市場規模 メキシコの獣医麻酔市場規模 … - ヨーロッパの獣医麻酔市場規模 ドイツの獣医麻酔市場規模 イギリスの獣医麻酔市場規模 フランスの獣医麻酔市場規模 … - アジア太平洋の獣医麻酔市場規模 中国の獣医麻酔市場規模 インドの獣医麻酔市場規模 日本の獣医麻酔市場規模 … - その他地域の獣医麻酔市場規模 ・競争状況 ・市場機会・将来の動向 |
The veterinary anesthesia market is expected to register aCAGR of 6.5% during the forecast period.
Key Highlights
- The COVID-19 pandemic impacted the veterinary anesthesia market owing to the disruptions in the veterinary medical devices supply chain and cancellations of veterinary surgical procedures in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19.
- For instance, according to an article published in February 2021, the demand for veterinary services and visits to pet clinics reduced in Mexico during the COVID-19 pandemic, thus impacting the growth of the veterinary anesthesia market. However, the market recovered since the restrictions were lifted and pet clinic services resumed.
- In addition, the rising chronic diseases associated with surgical procedures and technological advancements in veterinary anesthesia are actively affecting the growth of the studied market.
- The recent years have observed a significant rise in the prevalence of veterinary chronic diseases, such as arthritis, chronic kidney disease, hepatitis, skin allergies (atopy), diabetes mellitus, Cushing’s and Addison’s disease, inflammatory bowel disease, hyperthyroidism (cats) and hypothyroidism (dogs), and many others. Hence, with the high prevalence of these diseases, the number of surgical procedures is expected to rise during the forecast period.
- According to the data reported by Frontiers of Veterinary Science, the prevalence of canine obesity and obesity-related metabolic dysfunction (ORMD), such as hypertension and fasting hypertriglyceridemia/hypercholesterolemia, was reported to be 40.9% and 20.4%, respectively, in Spain in 2021. The high prevalence of canine obesity is expected to increase the surgical procedures requiring anesthesia, thereby boosting market growth.
- Furthermore, an article published in the Journal of Animal Science in July 2021 reported that osteoarthritis (OA) affects about 20% of all adult dogs and over 90% of dogs above five years of age in North America every year. The high burden of the disease requires the use of anesthesia during surgical treatment, thereby propelling the market growth.
- The strategic initiatives adopted by key market players, such as product launches, approvals, and partnerships, are driving the market growth. For instance, in April 2021, Shenzhen Mindray Animal Medical Technology Co., Ltd. launched its new veterinary anesthesia device called Veta 5 or Veta 3. The product launches are anticipated to propel the market growth.
- However, the high cost of anesthesia machines will likely impede the market growth.
Veterinary Anesthesia Market Trends
Companion Segment is Expected to Hold a Significant Market Share Over the Forecast Period
- The companion animal segment is expected to hold a significant market share owing to the increasing prevalence of chronic diseases, rise in pet adoption, and rising pet insurance globally.
- According to the People’s Dispensary for Sick Animals (PDSA) animal wellbeing June 2021 report, 2 million people in the United Kingdom adopted a pet between March 2020 to May 2021. Of these pets, 10% were dogs, 8% were cats, and 13% were rabbits. Also, according to Der Deutsche Heimtiermarkt, 47% of the households in Germany had pets in 2021.
- Additionally, there were 34.7 million pets in the country, including decorative birds, small animals, and dogs and cats. The number of cats adopted was higher in Germany than in dogs, as 16.7 million cats live in 26% of German households compared to 10.3 million dogs in 21% of households. Such a high rate of pet adoption and population in different countries has increased the focus on the healthcare of animals. This has increased the incidences of veterinary diagnostics, thus increasing the demand for anesthesia required for treating chronic diseases, thereby boosting the market.
- Furthermore, according to the American Pet Products Association (APPA), it was estimated that in 2021 around USD 109.6 billion was spent on pets in the United States, an increase of approximately 6% from the previous year. The region’s increasing pet adoption rate is also forcing more people to pay attention to the availability of pet insurance. Hence, pet owners are spending more on pet health care. This is opening up possibilities for the creation and availability of advanced and effective anesthesia for the effective treatment of animals, which is expected to drive market growth over the coming years.
- Besides, the strategic initiatives adopted by key players, such as product launches and approvals, fuel the segment growth. For instance, in January 2022, Dechra Pharmaceuticals acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant inhalation anesthesia solutions from Halocarbon Life Sciences, used for animal surgeries. These developments are projected to propel the segment’s growth.
North America is Expected to Hold a Significant Market Share Over The Forecast Period.
- North America is expected to hold a significant share of the veterinary anesthesia market due to increased awareness about animal health and ongoing technological innovations.
- The increasing number of pet insurance in the region is expected to increase the market growth. For instance, according to the 2022 statistics published by the Insurance Information Institute, it has been observed that in the United States, 3.9 million pets were insured at the end of 2021, with an increase of 20% compared to 2020. In addition, California (19.3%), New York (8.4%), and Florida (6.1%) were the three states with the highest percentage of insured pets in 2021.
- Also, it has been observed that in Canada 432,533 pets were insured at the end of 2021, with an increase of 22.7% compared to 2020. Also, Ontario (38.9%), British Columbia (20.3%), and Alberta (18.9%) were the three states with the highest percentage of insured pets in 2021. The rising number of pet insurance in the region is also expected to increase the market growth.
- Furthermore, the research and development activities of various market players to develop effective veterinary anesthesia, product launches, approvals, and partnerships are anticipated to boost the market growth. For instance, in April 2022, Respirair Global collaborated with Dechra United States for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. The partnership aims to expand veterinary anesthesia and develop technologically advanced products. Such developments are anticipated to boost the market growth in the region during the analysis period.
Veterinary Anesthesia Market Competitor Analysis
The veterinary anesthesia market is fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies with major or significant market shares. Some key players are JD Medical Dist. Co. Inc., Kent Scientific Corporation, Midmark Corporation, Mindray Medical International Limited, Patterson Scientific, ICU Medical, Inc, Supera Anesthesia Innovations, Tecnologia Veterinaria y Medica, S.L, Dispomed Ltd., DRE Veterinary, Vetland Medical Sales & Services, LLC, Avante Health Solutions, Prunus Medical, and Dispomed Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Chronic Diseases And Associated Surgical Procedures
4.2.2 Technological Advancements in Veterinary Anesthesia
4.3 Market Restraints
4.3.1 High Cost of Anesthesia Machines
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 By Product
5.1.1 On Trolley
5.1.2 Wall Mounted
5.1.3 Table top
5.2 By Animals
5.2.1 Companion
5.2.2 Livestock
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 JD Medical Dist. Co. Inc.
6.1.2 Kent Scientific Corporation
6.1.3 Midmark Corporation
6.1.4 Mindray Medical International Limited
6.1.5 Patterson Scientific
6.1.6 ICU Medical, Inc.
6.1.7 Supera Anesthesia Innovations
6.1.8 Tecnologia Veterinaria y Medica, S.L
6.1.9 Vetland Medical Sales & Services, LLC
6.1.10 Avante Health Solutions
6.1.11 Dispomed Ltd.
6.1.12 Prunus Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
